:: Main :: About :: Current Issue :: Archive :: Submit :: Contact ::
:: Volume 2, Issue 1 And 2 (5-2015) ::
vacres 2015, 2(1 And 2): 24-28 Back to browse issues page
Construction of pIRES2 vector encoding truncated NS3 of HCV and IL-18 for DNA vaccine studies
M Zavvar, A Moshiri, F Motevali, MH Pouriayevali *, G Bahramali
Tarbiat Modares University
Abstract:   (5081 Views)

Introduction: Long term complications of hepatitis C virus (HCV) infection include fibrosis, cirrhosis, and hepatocellular carcinoma and although the disease is treatable with the newly introduced direct acting antivirals, but factors such as drug resistance, viral genotype and adverse effects can limit the effectiveness of therapy. Therefore, development of effective, safe and affordable prophylactic and therapeutic vaccines is a global goal. This study was undertaken for construction of a vector containing the coding region for  a truncated form of nonstructural protein 3 (NS3) of HCV and IL-18 cytokine gene fused to murine Fcy2a as molecular adjuvantfor assessmentas a DNA vaccine candidate.  Methods: A truncated form of NS 3 was amplified and cloned in pIRES2 containing IL-18 hybrid gene. Expression of the truncated NS3 and bioactivity of IL-18 fusion protein were assessed in transfected HEK293 T cells. Physicochemical properties determination, secondary structure, 3D modelingand T-cell epitope predictionswere made using various online tools. Results: In silico analysis of truncated NS3 predicted a molecular weight of 32.35 kDa containing epitopic regions with the highest scores for binding to MHC complex. 3D model of IL-18showed that fusion with murine Fc had not impaired the structure. HEK293 T cells were successfully transfected with pIRES-IL18-NS3construct and expression of truncated NS3 with an apparent molecular weight of approximately 32 kDa was confirmed by Western blotting.  Conclusion: Despite the advantages, widespread use of DNA vaccination has been hampered by low immunogenicity. Truncated NS3 was expressed albeit in low amount with bioactive IL-18 fusion proteinas a molecular adjuvant Immunogenicity assessment of this novel combination as a DNA vaccine candidate is underway.

Keywords: HCV, NS3, IL18, DNA vaccine, Adjuvant
Full-Text [PDF 522 kb]   (2098 Downloads)    
Type of Study: Original article |
Received: 2015/10/31 | Accepted: 2015/10/31 | Published: 2015/10/31
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zavvar M, Moshiri A, Motevali F, Pouriayevali M, Bahramali G. Construction of pIRES2 vector encoding truncated NS3 of HCV and IL-18 for DNA vaccine studies. vacres. 2015; 2 (1 and 2) :24-28
URL: http://vacres.pasteur.ac.ir/article-1-55-en.html

Volume 2, Issue 1 And 2 (5-2015) Back to browse issues page
Vaccine Research Vaccine Research
Persian site map - English site map - Created in 0.18 seconds with 30 queries by YEKTAWEB 4247
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.